References
- Quinones S. Dreamland: The True Tale of America’s Opiate Epidemic. New York: Bloomsbury Publishing; 2015.
- Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245–258. doi:10.1016/s0749-3797(98)00017-8.
- Friedman J, Akre S. COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January‒July 2020. Am J Public Health. 2021;111(7):1284–1291. doi:10.2105/ajph.2021.306256.
- Quinones S. The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth. New York: Bloomsbury Publishing; 2021.
- Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2023. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed October 5, 2022.
- National Institute on Drug Abuse (NIDA). Drug overdose death rates. National Institutes of Health; 2023. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates Published June 30, 2023. Accessed July 3, 2023.
- Macy B. Dopesick: Dealers, Doctors, and the Company That Addicted America. London: Head of Zeus; 2019.
- Hancock SD, McKim WA. Drugs and Behavior: An Introduction to Behavioral Pharmacology. 8th ed. New York, NY: Pearson; 2017.
- Drug Enforcement Administration (DEA). The 2016 heroin signature program report. DEA Intelligence Report DEA-DCW-DIR-035-18. https://www.dea.gov/sites/default/files/2018-10/Heroin%20Signature%20Report%20FINAL.pdf. Published October 2018. Accessed October 5, 2022.
- Gibson A, Degenhardt L, Topp L, et al. Global and Australian Heroin Markets. National Drug and Alcohol Research Centre Technical Report 167. Sydney: University of New South Wales; 2003. https://ndarc.med.unsw.edu.au/resource/global-and-australian-heroin-markets. Accessed October 5, 2022.
- Felbab-Brown V. Poppy, eradication, and alternative livelihoods in Mexico. The Brookings Institute; 2018. https://www.brookings.edu/articles/poppy-eradication-and-alternative-livelihoods-in-mexico/2020. Accessed October 5, 2022.
- Drug Scheduling. Drug Enforcement Administration (DEA). https://www.dea.gov/drug-information/drug-scheduling. Accessed July 2, 2022.
- Le Cour Grandmaison R, Morris N, Smith B. The last harvest? From the US fentanyl boom to the Mexican opium crisis. J Illicit Econ Dev. 2019;1(3):312–329. doi:10.31389/jied.45.
- National Drug Intelligence Center (NDIC). Overview. Oxycontin diversion and abuse. https://www.justice.gov/archive/ndic/pubs/651/overview.htm. Published January 2001. Accessed July 5, 2022.
- Stanley TH. The history and development of the fentanyl series. J Pain Symptom Manage. 1992;7(suppl 3):S3–7. doi:10.1016/0885-3924(92)90047-l.
- Stanley TH, Egan TD, Van Aken H. A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg. 2008;106(2):451–462. doi:10.1213/ane.0b013e3181605add.
- Comer SD, Cahill CM. Fentanyl: receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019;106:49–57. doi:10.1016/j.neubiorev.2018.12.005.
- Finch JS, DeKornfeld TJ. Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic. J Clin Pharmacol J New Drugs. 1967;7(1):46–51. doi:10.1002/j.1552-4604.1967.tb00029.x.
- Rosal NR, Thelmo FL, Tzarnas S, DiCalvo L, Tariq S, Grossman C. Wooden chest syndrome: a case report of fentanyl-induced chest wall rigidity. J Investig Med High Impact Case Rep. 2021;9:232470962110340. doi:10.1177/23247096211034036.
- Drug Enforcement Administration (DEA). Drug Enforcement Administration announces the seizure of over 379 million deadly doses of fentanyl in 2022. https://www.dea.gov/press-releases/2022/12/20/drug-enforcement-administration-announces-seizure-over-379-million-deadly. Published December 20, 2022. Accessed January 1, 2023.
- Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol (Phila). June 2008;46(6):501–506. doi:10.1080/15563650701877374.
- Commission on combating synthetic opioid trafficking: final report. RAND Corporation. https://www.rand.org/pubs/external_publications/EP68838.html. Published February 8, 2022. Accessed July 15, 2022.
- Fentanyl & Opioid Response Toolkit for Schools. Oregon health authority, Oregon department of education. https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/FentanylOpioidResponseToolkit.pdf. Published December 2022. Accessed July 15, 2022.
- National Institute on Drug Abuse (NIDA). Law enforcement seizures of pills containing fentanyl increased dramatically between 2018-2021. National Institute on Drug Abuse Website; March 31, 2022. https://nida.nih.gov/news-events/news-releases/2022/03/law-enforcement-seizures-of-pills-containing-fentanyl-increased-dramatically-between-2018-2021. Accessed December 2, 2022.
- Palamar JJ, Ciccarone D, Rutherford C, Keyes KM, Carr TH, Cottler LB. Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021. Drug Alcohol Depend. 2022;234:109398. doi:10.1016/j.drugalcdep.2022.109398.
- One Pill Can Kill. Drug Enforcement Administration (DEA). https://www.dea.gov/onepill. Accessed January 5, 2023.
- Cartus AR, Li Y, Macmadu A, et al. Forecasted and observed drug overdose deaths in the US during the COVID-19 pandemic in 2020. JAMA Netw Open. 2022;5(3):e223418. doi:10.1001/jamanetworkopen.2022.3418.
- O’Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls — United States, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70(50):1740–1746. doi:10.15585/mmwr.mm7050e3.
- The economic toll of the opioid crisis reached nearly $1.5 trillion in 2020. Joint economic committee democrats. United States Senate. https://www.jec.senate.gov/public/index.cfm/democrats/2022/9/the-economic-toll-of-the-opioid-crisis-reached-nearly-1-5-trillion-in-2020. Published September 28, 2022. Accessed December 12, 2022.
- Levin D. Teaching children how to reverse an overdose. New York Times. https://www.nytimes.com/2020/02/23/us/opioids-tennessee-narcan-training.html. Published February 23, 2020. Accessed July 1, 2022.
- Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT, Alegria M. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16(11):e1002922. Published November 5, 2019. doi:10.1371/journal.pmed.1002922.
- Center for Behavioral Health Statistics and Quality. 2016 National survey on drug use and health: methodological summary and definitions. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/sites/default/files/NSDUH-MethodSummDefs-2016/NSDUH-MethodSummDefs-2016.htm#seca Published September 2017. Accessed July 5, 2022.
- Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398–1400. doi:10.1001/jama.2022.2847.
- Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379. doi:10.1001/jamapsychiatry.2022.0004.
- Kelly BC, Vuolo M, Frizzell LC. Pediatric drug overdose mortality: contextual and policy effects for children under 12 years. Pediatr Res. 2021;90(6):1258–1265. doi:10.1038/s41390-021-01567-7.
- Wang GS, Olsen H, Severtson G, Green JL, Dart RC. The impact of the prescription opioid epidemic on young children: trends and mortality. Drug Alcohol Depend. 2020;211:107924. doi:10.1016/j.drugalcdep.2020.107924.
- Office of National Drug Control Policy (ONDCP). National Drug Control Strategy. The White House, Executive Office of the President of the United States. Office of National Drug Control Policy. https://www.whitehouse.gov/wp-content/uploads/2022/04/National-Drug-Control-2022Strategy.pdf. Published 2022. Accessed July 1, 2022.
- Fishbein DH, Sloboda Z. A national strategy for preventing substance and opioid use disorders through evidence-based prevention programming that fosters healthy outcomes in our youth. Clin Child Fam Psychol Rev. 2023;26(1):1–16. doi:10.1007/s10567-022-00420-5.
- Agency for Healthcare Research and Quality. Pathways community HUB manual: a guide to identify and address risk factors, reduce costs, and improve outcomes. US Dept of Health and Human Services; HHS Publication 15(16)-0070-EF. https://www.ahrq.gov/innovations/hub/index.html. Published 2021. Accessed February 15, 2023.
- Weist MD, Eber L, Horner R, et al. Improving multitiered systems of support for students with “internalizing” emotional/behavioral problems. J Posit Behav Interv. 2018;20(3):172–184. doi:10.1177/1098300717753832.
- Eber L, Barrett S, Perales K, et al. Advancing education effectiveness: interconnecting school mental health and school-wide PBIS, volume 2: an implementation guide. Center on Positive Behavioral Interventions and Supports. https://www.pbis.org/resource/interconnecting-school-mental-health-and-pbis-volume-2. Published September 9, 2020. Revised September 21, 2020. Accessed August 1, 2023.
- Weist MD, Splett JW, Halliday CA, et al. A randomized controlled trial on the interconnected systems framework for school mental health and PBIS: focus on proximal variables and school discipline. J Sch Psychol. 2022;94:49–65. doi:10.1016/j.jsp.2022.08.002.
- Gordon RS Jr. An operational classification of disease prevention. Public Health Rep. 1983;98:107–109.
- Mrazrek PJ, Haggerty RJ, eds. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC: National Academy Press; 1994.
- Koh HK. Community-based prevention and strategies for the opioid crisis. JAMA. 2017;318(11):993–994. doi:10.1001/jama.2017.13767.
- Effective medical treatment of opiate addiction. National consensus development panel on effective medical treatment of opiate addiction. JAMA. 1998;280(22):1936–1943. doi:10.1001/jama.280.22.1936.
- Substance Use and Mental Health Services Administration. Medications for substance use disorders. US Dept of Health and Human Services. https://pcssnow.org/samhsa-medication-assisted-treatment-a-standard-of-care/. Published February 2014. Accessed August 1, 2022.
- Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. doi:10.1542/peds.2016-1893.
- Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-assisted treatment for opioid-use disorder. Mayo Clin Proc. 2019;94(10):2072–2086. doi:10.1016/j.mayocp.2019.03.029.
- Amram O, Rosenkrantz L, DDes SA, Schuurman N, Panwala VJ, Joudrey PJ. Availability of timely methadone treatment in the United States and Canada during COVID-19: a census tract-level analysis. Drug Alcohol Depend. 2023;245:109801. doi:10.1016/j.drugalcdep.2023.109801.
- Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395(10241):1938–1948. doi:10.1016/S0140-6736(20)30852-7.
- Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. Published April 26, 2017. doi:10.1136/bmj.j1550.
- Daniulaityte R, Sweeney K, Ki S, Doebbeling BN, Mendoza N. “They say it’s fentanyl, but they honestly look like Perc 30s”: initiation and use of counterfeit fentanyl pills. Harm Reduct J. 2022;19(1):52. Published May 25, 2022. doi:10.1186/s12954-022-00634-4.
- Substance Abuse and Mental Health Services Administration. SAMHSA opioid overdose prevention toolkit. US Dept of Health and Human Services. HHS Publication (SMA) 18 4742. https://store.samhsa.gov/sites/default/files/d7/priv/sma18-4742.pdf. First printed 2013. Revised 2014, 2016, 2018. Accessed August 1, 2022.
- National Harm Reduction Coalition. Responding to opioid overdose. https://harmreduction.org/issues/overdose-prevention/overview/overdose-basics/responding-to-opioid-overdose/. Published September 1, 2020. Accessed August 1, 2022.
- Waterloo Region Crime Prevention Council. Between life and death: the barriers to calling 9-1-1 during an overdose emergency. https://preventingcrime.ca/wp-content/uploads/2015/05/911Report.pdf. Published September 2012. Accessed August 1, 2022.
- Banta-Green CJ, Beletsky L, Schoeppe JA, Coffin PO, Kuszler PC. Police officers’ and paramedics’ experiences with overdose and their knowledge and opinions of Washington State’s drug overdose-naloxone-Good Samaritan law. J Urban Health. 2013;90(6):1102–1111. doi:10.1007/s11524-013-9814-y.
- University of Wisconsin Population Health Institute. Good Samaritan Drug Overdose Laws. County Health Rankings & Roadmaps. https://www.countyhealthrankings.org/take-action-to-improve-health/what-works-for-health/strategies/good-samaritan-drug-overdose-laws. Published February 27, 2017. Updated June 3, 2021. Accessed August 1, 2022.
- Access to Naloxone can save a life during an opioid overdose. US Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/access-naloxone-can-save-life-during-opioid-overdose. Published March 29, 2023. Accessed August 1, 2022.
- Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019;179(6):805–811. doi:10.1001/jamainternmed.2019.0272.
- Baca MA, Chambers S, Madaras A. Adaptations to overdose education naloxone distribution programs for high-risk adolescents in juvenile detention: positive outcomes from the Overdose rescue net program. J Adolesc Health. 2020;66(2):S44. doi:10.1016/j.jadohealth.2019.11.087.
- Levasseur S, Nelson L, Crowe D, Major KES. Naloxone in the school setting. National Association of School Nurses. https://eric.ed.gov/?id=ED609438. Published June 2020. Accessed August 1, 2022.
- Kern L, Weist MD, Mathur SR, Barber BR. Empowering school staff to implement effective school mental health services. Behav Disord. 2021;47(3):207–219. doi:10.1177/01987429211030860.
- Weist MD. Fulfilling the promise of school-based mental health: moving toward a Public Mental Health Promotion approach. J Abnorm Child Psychol. 2005;33(6):735–741. doi:10.1007/s10802-005-7651-5.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013. doi:10.1176/appi.books.9780890425596.
- Marsden J, Tai B, Ali R, Hu L, Rush AJ, Volkow N. Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective? Addiction. 2019;114(8):1346–1353. doi:10.1111/add.14546.
- Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP. Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 2014;133(5):819–826. doi:10.1542/peds.2013-2346.
- Levy S, Weiss R, Sherritt L, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–828. doi:10.1001/jamapediatrics.2014.774.
- Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23(2):63–75. doi:10.1097/HRP.0000000000000075.
- Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):CD002209. Published July 8, 2009. doi:10.1002/14651858.CD002209.pub2.
- Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2):CD002207. Published February 6, 2014. doi:10.1002/14651858.CD002207.pub4.
- National Institute on Drug Abuse (NIDA). To end the drug crisis, bring addiction out of the shadows. National Institute on Drug Abuse website. https://nida.nih.gov/about-nida/noras-blog/2021/11/to-end-drug-crisis-bring-addiction-out-shadows. November 8, 2021. Accessed September 3, 2023.
- Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial [published correction appears in JAMA. 2009 Feb 25;301(8): 830] [published correction appears in JAMA. 2013 Apr 10;309(14): 1461]. JAMA. 2008;300(17):2003–2011. doi:10.1001/jama.2008.574.
- Feder KA, Krawczyk N, Saloner B. Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder. J Adolesc Health. 2017;60(6):747–750. doi:10.1016/j.jadohealth.2016.12.023.
- Goffman E. Stigma: Notes on the Management of Spoiled Identity. New York: Simon and Schuster, Inc.; 1963.
- Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24. doi:10.1016/s0277-9536(02)00304-0.
- Tsai AC, Kiang MV, Barnett ML, et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019;16(11):e1002969. Published November 26, 2019. doi:10.1371/journal.pmed.1002969.
- Weist MD, Mellin EA, Garbacz SA, Anderson-Butcher D. Reducing the use of language that stigmatizes students. NASP Communique. 2019;47:22–23.
- Stuart H. Reducing the stigma of mental illness. Glob Ment Health (Camb). 2016;3:e17. Published May 10, 2016. doi:10.1017/gmh.2016.11.
- Bloomberg American Health Initiative. Guiding principles for addressing the stigma on opioid addiction. https://americanhealth.jhu.edu/news/guiding-principles-addressing-stigma-opioid-addiction Published December 5, 2019. Accessed December 15, 2022.
- Huggins A, Weist MD, McCall M, Kloos B, Miller E, George MW. Qualitative analysis of key informant interviews about adolescent stigma surrounding use of school mental health services. Int J Ment Health Promot. 2016;18(1):21–32. doi:10.1080/14623730.2015.1079424.